Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-03-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000159263.50305.BDPMID 15781743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study.

  2004cited by this paper
• The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

  2004cited by this paper
• Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.

  2004cited by this paper
• Differences in Medical Care and Disease Outcomes Among Black and White Women With Heart Disease

  2003cited by this paper
• Inhibition of Plasminogen Activation by Lipoprotein(a)

  2003cited by this paper
• Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads

  2003cited by this paper
• Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.

  2002cited by this paper
• Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner: A Study With Different-Length Recombinant Apo(a), Native Lp(a), and Monoclonal Antibody

  2002cited by this paper
• Lipoprotein(a) Enhances Advanced Atherosclerosis and Vascular Calcification in WHHL Transgenic Rabbits Expressing Human Apolipoprotein(a)*

  2002cited by this paper
• Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

  2001cited by this paper
• Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.

  2001cited by this paper
• High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men

  2000cited by this paper
• Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.

  2000cited by this paper
• Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies

  2000cited by this paper
• Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons.

  1999cited by this paper
• Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

  1999cited by this paper
• Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?

  1999cited by this paper
• Lipoprotein(a): intrigues and insights.

  1999cited by this paper
• Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks.

  1998cited by this paper
• Echocardiographic detection of regional diastolic dysfunction in patients with coronary artery disease and normal wall motion

  1998cited by this paper
• Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology.

  1998cited by this paper
• Serum distribution of lipoprotein(a) in African Americans and Nigerians: Potential evidence for a genotype‐environmental effect

  1997cited by this paper
• Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia.

  1997cited by this paper
• Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans.

  1996cited by this paper
• Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

  1996cited by this paper
• Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature.

  1996cited by this paper
• Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a).

  1995cited by this paper
• An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk.

  1995cited by this paper
• No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans.

  1995cited by this paper
• Lipoprotein (a) and coronary heart disease.

  1995cited by this paper
• Lipoprotein(a) and coronary heart disease.

  1994cited by this paper
• Mortality rates and risk factors for coronary disease in black as compared with white men and women.

  1993cited by this paper
• Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women.

  1993cited by this paper
• Serum lipoprotein(a) levels in elderly black and white men in the Charleston Heart Study

  1993cited by this paper
• Has lipoprotein 'little' (a) shrunk?

  1993cited by this paper
• Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.

  1992cited by this paper
• Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients.

  1992cited by this paper
• Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

  1991cited by this paper
• The effect of known risk factors on the excess mortality of black adults in the United States.

  1990cited by this paper
• Quantification of coronary artery calcium using ultrafast computed tomography.

  1990cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta.

  1988cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B

  1985cited by this paper
• Black-white differences in plasma levels of apolipoproteins: the Evans County Heart Study.

  1984cited by this paper
• Radioimmunoassay of human plasma Lp(a) lipoprotein.

  1977cited by this paper

• Lp(a) across the spectrum of disease in a Spanish population: A watchword for more answers and access.

  2026cites this paper
• Lipoprotein(a) epidemiology and role in secondary and primary-and-a-half cardiovascular prevention: From subclinical atherosclerosis to coronary events.

  2026cites this paper
• Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and management.

  2026cites this paper
• The Association of Lipoprotein(A) and Coronary Artery Calcium in Primary Prevention Patients—Data from the STAR-Lp(A) Study

  2025cites this paper
• Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.

  2025cites this paper
• Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults.

  2025cites this paper
• The Association between Lipoprotein(a) and Coronary Artery Calcification in Elderly Patients with Diabetes: A Cross-Sectional Study

  2025cites this paper
• Evolving concepts of low‐density lipoprotein: From structure to function

  2025cites this paper
• Association between lipoprotein(a) and atherosclerosis with different diabetic status: a cross-sectional study in a Chinese population

  2025cites this paper
• Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease.

  2025cites this paper
• Genetic association of circulating lipids and lipid-lowering drug targets with vascular calcification.

  2025cites this paper
• Lipoprotein(a) and Its Role in Peripheral Arterial Disease: A Narrative Review

  2025cites this paper
• Sex-specific influence of Lipoprotein(a) levels on coronary plaque characteristics: - The COPRODUCTION Registry -

  2025cites this paper
• Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida

  2024cites this paper
• The Mysterious Lipoprotein(a): Moving Towards Further Understanding of its Atherogenic Role.

  2024cites this paper
• Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.

  2024cites this paper
• Lipoprotein(a) is Associated with Increased Low-Density Plaque Volume

  2024cites this paper
• Elevated Lipoprotein(a) With Zero Coronary Artery Calcium: A Silent Threat or a Clinical Paradox?

  2024cites this paper
• Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus

  2024cites this paper
• LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics.

  2023cites this paper
• Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis.

  2023cites this paper
• Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.

  2022cites this paper
• Coronary artery calcium scoring as a tool for risk stratification in patients with an elevated lipoprotein(a) level

  2022cites this paper
• African genetic ancestry and protection against fatty liver disease

  2022cites this paper
• Coronary Artery Calcium-Based Approach to Lipid Management

  2022cites this paper
• The Curious Case of Synergy between Lipoprotein (a), Coronary Calcification, and Cardiovascular Disease Risk.

  2022cites this paper
• Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study

  2022cites this paper
• Lipoprotein(a) and Coronary Calcium: Clinical Management and Potential Design of Primary Prevention Trials.

  2022cites this paper
• Lipoprotein(a) and CT Angiography: Novel Insights Into High-Risk Plaque Progression.

  2022cites this paper
• Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen.

  2021cites this paper
• Lipoprotein (a)-mediated vascular calcification: population-based and in vitro studies.

  2021cites this paper
• Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.

  2021cites this paper
• Coronary calcification is associated with elevated serum lipoprotein (a) levels in asymptomatic men over the age of 45 years

  2021cites this paper
• Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification

  2020cites this paper
• Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: The Multi-Ethnic Study of Atherosclerosis.

  2020cites this paper
• Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.

  2020cites this paper
• Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease

  2020cites this paper
• RIC___Vol 72___Num 02___March-April 2020___ABRIL'20___V09.indd

  2020cites this paper
• Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

  2019cites this paper
• Evaluating the Potential Association Between Lipoprotein(a) and Atherosclerosis (from the Mediators of Atherosclerosis Among South Asians Living in America Cohort).

  2019cites this paper
• Estimation of apolipoprotein A in early onset ST-segment elevation myocardial infarction.

  2019cites this paper
• Racial Differences in Cardiovascular Biomarkers in the General Population

  2019cites this paper
• Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.

  2018cites this paper
• Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries

  2018cites this paper
• Sex-Based Differences in Cardiometabolic Biomarkers

  2017cites this paper
• The dark side of innate immune memory: the development of atherosclerosis

  2017cites this paper
• LPA Gene, Ethnicity, and Cardiovascular Events

  2017cites this paper
• The renaissance of lipoprotein(a): Brave new world for preventive cardiology?

  2017cites this paper
• Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries

  2017cites this paper
• Lipoprotein (a) and Cardiovascular Risk: The Show Must go on.

  2017cites this paper
• Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans

  2016cites this paper
• The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis

  2016cites this paper
• Structure, function, and genetics of lipoprotein (a)

  2016cites this paper
• Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis

  2016cites this paper
• Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis

  2016cites this paper
• Risk Factors in the Progression of Subclinical Atherosclerosis in Women With Systemic Lupus Erythematosus

  2014cites this paper
• Prevalence and determinants of hypertension in Estonian adults

  2014cites this paper
• Analysis of Lipoprotein(a) Receptors: Roles in Catabolism and Pericellular Plasminogen Activation

  2014cites this paper
• Lipoprotein(a) as a therapeutic target in cardiovascular disease

  2014cites this paper
• Circulating Lp(a):LDL Complexes Contain LDL Molecules Proportionate to Lp(a) Size and Bind to Galectin-1: A Possible Route for LDL Entry into Cells

  2014cites this paper
• Dyslipidaemia related to insulin resistance and cardiovascular disease in South Asian and West African populations.

  2014cites this paper
• Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis: A Prospective Mendelian Randomization Study and Replication in a Case–Control Cohort

  2014cites this paper
• Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator

  2013cites this paper
• Lipoprotein(a): resurrected by genetics

  2013cites this paper
• Lipoprotein (a) is independently correlated with coronary artery calcification.

  2013cites this paper
• Serum Lipoprotein(a) Positively Correlates with Coronary Artery Calcification in Low-Risk Chinese Han Patients: A Study from a Single Center

  2013cites this paper
• Single-Nucleotide Polymorphisms in LPA Explain Most of the Ancestry-Specific Variation in Lp(a) Levels in African Americans

  2011influential citation
• Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice.

  2011cites this paper
• Abnormal Lipoprotein(a) Levels Predict Coronary Artery Calcification in Southeast Asians but Not in Caucasians: Use of Noninvasive Imaging for Evaluation of an Emerging Risk Factor

  2011cites this paper
• Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women.

  2011cites this paper
• Non-Invasive Measurement of Coronary Atherosclerosis

  2009cites this paper
• Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study

  2009cites this paper
• Lipoprotein a: where are we now?

  2009cites this paper
• LPA and PLG Sequence Variation and Kringle IV-2 Copy Number in Two Populations

  2008cites this paper
• Association of single nucleotide polymorphisms in the LPA gene region with serum Lp(a) levels and myocardial infarction

  2008cites this paper
• The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study

  2008cites this paper
• Lipoprotein(a) as an Emerging Risk Factor for Atherothrombosis

  2007cites this paper
• Racial disparity in clinical outcomes following primary percutaneous coronary intervention for ST elevation myocardial infarction: influence of process of care.

  2007cites this paper
• Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.

  2006cites this paper
• Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein

  2005cites this paper